Navigation Links
New research shows program effective in educating parents about prevention of shaken baby syndrome
Date:3/2/2009

(Seattle, WA; Vancouver, BC)-- New studies in the United States and Canada show that educational materials aimed at preventing shaken baby syndrome increased knowledge of new mothers about infant crying, the most common trigger for people abusing babies by shaking them. The study of mothers in Seattle is featured in the March issue of Pediatrics, and a partner study in Vancouver, British Columbia appears this month in The Canadian Medical Association Journal.

Each year in the United States, an estimated 1,300 infants are hospitalized or die from shaken baby syndrome. One in four babies will die as a result of their injuries, and among those who survive, approximately 80 percent will suffer brain injury, blindness and deafness, fractures, paralysis, cognitive and learning disabilities, or cerebral palsy.

"Typically, crying begins within two weeks of birth so it's imperative that new parents receive information and learn coping strategies early," says Fred Rivara, MD, MPH and co-author of the Seattle study. Dr. Rivara is an investigator at the Harborview Injury Prevention and Research Center, and vice-chair of pediatrics at the University of Washington.

Both studies were randomized controlled trials testing of "The Period of PURPLE Crying," an educational program that includes a 12-minute DVD and information booklet. In Seattle, Dr. Rivara was joined by Dr. Ronald Barr, lead author of both studies and director of community child health at the Child & Family Research Institute and professor of pediatrics in the Faculty of Medicine at the University of British Columbia.

The Seattle study involved 2,738 mothers of new infants. Half the women enrolled in the study received the PURPLE materials while half received information on infant safety. Mothers who received the PURPLE materials scored six percent higher in knowledge about crying and one percent higher in knowledge about shaking. They were six percent more likely to share information with caregivers about strategies for coping with the frustration of infant crying, and seven percent more likely to warn caregivers of the dangers of shaking.

Like their American counterparts, Vancouver mothers who received the PURPLE materials scored 6 percent higher in knowledge about crying, were 13 percent more likely to share information with caregivers about coping with inconsolable crying, 12.9 percent more likely to share information about the dangers of shaking, and 7.6 percent more likely to share information about crying.

"Changing knowledge is a critical first step in changing behavior, and this is important public health work because the results show it's possible to change people's ideas about crying." said Dr. Barr. PURPLE materials are designed to teach parents that crying is normal and frustrating for caregivers, and they list the following features as typical:

  • Peak pattern, when crying increases, peaks in second month, then declines
  • Unexpected timing of prolonged crying
  • Resistance to soothing
  • Pain-like look on the face
  • Long crying bouts
  • Evening and late afternoon clustering


'/>"/>

Contact: Kellie Tormey
ktormey@u.washington.edu
206-744-9430
University of Washington - Harborview Medical Center
Source:Eurekalert

Related medicine news :

1. Scripps research scientists engineer new type of vaccination that provides instant immunity
2. ProteoTech Receives Funding From The Michael J. Fox Foundation for Parkinsons Disease Research to Develop Tools for Imaging Alpha-Synuclein Aggregation in Living Parkinsons Brain
3. Sex is in the brain, says new research from Stanford
4. U-M Researchers ID Gene Involved in Pancreatic Cancer
5. Motor behavioral research at UH moves to prestigious Texas Medical Center
6. ACORNs Success in Delivering Top Quality Research Portfolio to Community-Based Oncology Practices Presented at Annual Investigator Meeting
7. Researchers identify potential therapeutic target in osteosarcoma
8. UT Southwestern teaching hospital halves its rate of premature births, researchers find
9. CTI Focuses on Late-Stage Drug Approvals and Commercialization and Cuts Operating Costs: to Close Bresso Research Center
10. MS Research, Funding Speed Development of New Therapies
11. Effective mentoring critical to HIV/AIDS research efforts
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/28/2017)... ... April 28, 2017 , ... Ushio America proudly introduces the ... instant energy-saving solution for F32T8 fluorescent lamps on most instant-start and programmed-start electronic ... hour rated lamps utilize the existing electronic ballast, saving labor and maintenance costs. ...
(Date:4/28/2017)... ... April 28, 2017 , ... Datta Endoscopic Back ... joined the revolutionary endoscopic practice under Dr. Datta. Patel is a Board Certified ... The patented, revolutionary eDiscSculpt Technique created and used by Datta Endoscopic is unlike ...
(Date:4/28/2017)... ... April 28, 2017 , ... The Texas Cord Blood ... to the labor and delivery team at Women’s Hospital at Renaissance in Edinburg for ... birth at the hospital and decide to donate. , “Women’s Hospital at Renaissance ...
(Date:4/28/2017)... ... April 28, 2017 , ... Early ... substantially improve drug safety and minimize the cost of development. In this webinar, ... inhibition using cell lines and for cardiac toxicity using induced pluripotent stem cells ...
(Date:4/28/2017)... (PRWEB) , ... April 28, 2017 , ... Bill Howe ... industry in the coastal communities. After Tina Howe joined the team, the Bill Howe ... employees, honest services at affordable rates, and giving back to the San Diego community ...
Breaking Medicine News(10 mins):
(Date:4/20/2017)... , April 20, 2017  CVS Pharmacy, the ... unveiled a new store design to enhance the ... healthier food, health-focused products and expanded beauty selections ... help customers discover new offerings. Together with its ... evolution of the customer experience at CVS Pharmacy.  ...
(Date:4/20/2017)... 20, 2017  AbbVie (NYSE: ABBV), a global ... of chronic hepatitis C virus (HCV) infected patients ... and compensated cirrhosis (Child-Pugh A) achieved sustained virologic ... with its investigational, pan-genotypic regimen of glecaprevir/pibrentasvir (G/P). ... following 12 weeks of G/P treatment without ribavirin. ...
(Date:4/20/2017)... 2017 Eyevensys, a private biotechnology ... gene expression technology that enables the safe, local, sustained ... a wide range of ophthalmic diseases, announces it has ... Regulatory Agency (MHRA) to advance its technology into clinical ... The ...
Breaking Medicine Technology: